Home > Health > £25,000 FUNDING PROVIDES LIFELINE FOR AWARD-WINNING CHARITY£25,000 FUNDING PROVIDES LIFELINE FOR AWA

£25,000 FUNDING PROVIDES LIFELINE FOR AWARD-WINNING CHARITY£25,000 FUNDING PROVIDES LIFELINE FOR AWA

Added: (Fri Feb 02 2001)

Pressbox (Press Release) - PHOTOGRAPHS AVAILABLE

News release is available online at www.prowse.co.uk/newsf.html

2 February 2001

A unique approach to the problems of drug and alcohol use has won a local charity honours and funding of £25,000 in national awards next month at the King’s Fund on 20 February.

The Cumbrian Alcohol and Drug Advisory Service (CADAS), which works to reduce the harm people in Cumbria suffer from alcohol and drug problems, is to be presented with a cheque at the GlaxoSmithKline Impact Awards 2000 for its excellent work in the community.

Using the approach that addiction often stems from an individual’s relationship problems, the charity has developed a tailored Peer counselling service pairing the client with a counsellor who they can identify with. The counsellor provides support and is someone that they can rely on. As a result CADAS has moved away from the idea that all peer counsellors should be in their thirties and forties and has included counsellors as young as 17 to work with teenagers. The scheme seems to be working with 76% of clients who used the service regularly in 1999/2000 reporting an improvement in their health.

Paul Brown, the Director of CADAS says that the money will help keep the organisation going - funding for core functions has been difficult to find.

“We’re grateful for being recognised for the work that we to do because it means that we have the money to build on this. Awards like this ensure the future of the agency,” says Paul.

Margaret Bailey of GlaxoSmithKline: “CADAS has taken an innovative approach that has meant that they have become a valued charity in Cumbria. Organisers have taken the initiative to try new practices and not restrict themselves by just following the way that others carried out projects before.”

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer." For company information visit GlaxoSmithKline on the World Wide Web at http://www.gsk.com

The King’s Fund aims to influence health policy and stimulate good practice in service provision.

-Ends-

Issued by Prowse &Co, on behalf of GlaxoSmithKline.

For further information, contact Deborah Fields or Peter Colegate on 01372 363 386.
PHOTOGRAPHS AVAILABLE

News release is available online at www.prowse.co.uk/newsf.html

2 February 2001

A unique approach to the problems of drug and alcohol use has won a local charity honours and funding of £25,000 in national awards next month at the King’s Fund on 20 February.

The Cumbrian Alcohol and Drug Advisory Service (CADAS), which works to reduce the harm people in Cumbria suffer from alcohol and drug problems, is to be presented with a cheque at the GlaxoSmithKline Impact Awards 2000 for its excellent work in the community.

Using the approach that addiction often stems from an individual’s relationship problems, the charity has developed a tailored Peer counselling service pairing the client with a counsellor who they can identify with. The counsellor provides support and is someone that they can rely on. As a result CADAS has moved away from the idea that all peer counsellors should be in their thirties and forties and has included counsellors as young as 17 to work with teenagers. The scheme seems to be working with 76% of clients who used the service regularly in 1999/2000 reporting an improvement in their health.

Paul Brown, the Director of CADAS says that the money will help keep the organisation going - funding for core functions has been difficult to find.

“We’re grateful for being recognised for the work that we to do because it means that we have the money to build on this. Awards like this ensure the future of the agency,” says Paul.

Margaret Bailey of GlaxoSmithKline: “CADAS has taken an innovative approach that has meant that they have become a valued charity in Cumbria. Organisers have taken the initiative to try new practices and not restrict themselves by just following the way that others carried out projects before.”

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer." For company information visit GlaxoSmithKline on the World Wide Web at http://www.gsk.com

The King’s Fund aims to influence health policy and stimulate good practice in service provision.

-Ends-

Issued by Prowse &Co, on behalf of GlaxoSmithKline.

For further information, contact Deborah Fields or Peter Colegate on 01372 363 386.

Submitted by:
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.